These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12023849

  • 1. Cellular mechanisms regulating non-haemostatic plasmin generation.
    Bass R, Ellis V.
    Biochem Soc Trans; 2002 Apr; 30(2):189-94. PubMed ID: 12023849
    [Abstract] [Full Text] [Related]

  • 2. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 3. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T, Kanse SM, May AE, Preissner KT.
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE, Saunders DN, Ranson M.
    Breast Cancer Res; 2007 Apr; 9(1):R14. PubMed ID: 17257442
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
    Gallicchio MA, Kaun C, Wojta J, Binder B, Bach LA.
    J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
    [Abstract] [Full Text] [Related]

  • 8. Urokinase-type plasminogen activator system and breast cancer (Review).
    Han B, Nakamura M, Mori I, Nakamura Y, Kakudo K.
    Oncol Rep; 2005 Jul; 14(1):105-12. PubMed ID: 15944776
    [Abstract] [Full Text] [Related]

  • 9. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K, Claffey KP, Dong M, Nambiar PR, Rosenberg DW.
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [Abstract] [Full Text] [Related]

  • 10. Urokinase receptor variants in tissue and body fluids.
    Høyer-Hansen G, Lund IK.
    Adv Clin Chem; 2007 May; 44():65-102. PubMed ID: 17682340
    [Abstract] [Full Text] [Related]

  • 11. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
    Binder BR, Mihaly J, Prager GW.
    Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
    [Abstract] [Full Text] [Related]

  • 12. Cellular receptors for plasminogen activators recent advances.
    Ellis V.
    Trends Cardiovasc Med; 1997 Oct; 7(7):227-34. PubMed ID: 21235889
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
    Tan X, Egami H, Nozawa F, Abe M, Baba H.
    Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
    [Abstract] [Full Text] [Related]

  • 14. Differential proteome expression associated with urokinase plasminogen activator receptor (uPAR) suppression in malignant epithelial cancer.
    Saldanha RG, Xu N, Molloy MP, Veal DA, Baker MS.
    J Proteome Res; 2008 Nov; 7(11):4792-806. PubMed ID: 18808175
    [Abstract] [Full Text] [Related]

  • 15. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.
    Blasi F.
    Bioessays; 1993 Feb; 15(2):105-11. PubMed ID: 8385942
    [Abstract] [Full Text] [Related]

  • 16. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
    Margheri F, D'Alessio S, Serratì S, Pucci M, Del Rosso A, Benelli R, Ferrari N, Noonan DM, Albini A, Fibbi G, Del Rosso M.
    Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
    [Abstract] [Full Text] [Related]

  • 17. Binding and activation of plasminogen at the surface of human keratinocytes.
    Reinartz J, Batrla R, Boukamp P, Fusenig N, Kramer MD.
    Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
    [Abstract] [Full Text] [Related]

  • 18. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG, Pass J, Illemann M, Høyer-Hansen G, Lund IK.
    J Immunol Methods; 2008 Nov 30; 339(1):55-65. PubMed ID: 18761343
    [Abstract] [Full Text] [Related]

  • 19. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U, Magdolen V, Hapke S, Schmitt M.
    Biol Chem; 2003 Aug 30; 384(8):1119-31. PubMed ID: 12974381
    [Abstract] [Full Text] [Related]

  • 20. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.
    Madsen CD, Sidenius N.
    Eur J Cell Biol; 2008 Sep 30; 87(8-9):617-29. PubMed ID: 18353489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.